These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4845676)

  • 1. Interpretation of diffusion susceptibility data obtained with 10-mug fucidin (sodium fusidate) disks against clinical isolates of Staphylococcus aureus.
    Traub WH; Kleber I
    Chemotherapy; 1974; 20(2):92-6. PubMed ID: 4845676
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sensitivity of Streptococcus aureus hospital strains to a new antibiotic, fucidin].
    Jakubicz P
    Pol Tyg Lek; 1971 Jun; 26(24):921-2. PubMed ID: 5561135
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
    Lemaire S; Van Bambeke F; Pierard D; Appelbaum PC; Tulkens PM
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sensitivity test of clinical isolates to fusidic acid].
    Kobayashi M; Yamamoto S; Takami H; Mihara K
    Jpn J Antibiot; 1971 Jun; 24(3):152-5. PubMed ID: 4397858
    [No Abstract]   [Full Text] [Related]  

  • 5. Fucidin-resistant staphylococci in current hospital practice.
    Pattison JR; Mansell PE
    J Med Microbiol; 1973 May; 6(2):235-44. PubMed ID: 4488470
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.
    Jones RN; Mendes RE; Sader HS; Castanheira M
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S477-86. PubMed ID: 21546624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
    Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
    BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of methicillin-resistant Staphylococcus aureus and slime-producing and non-slime-producing coagulase-negative staphylococci to fusidic acid.
    Huebner J; Kropec A; Engels I; Daschner F
    Chemotherapy; 1992; 38(4):206-10. PubMed ID: 1473358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in antibiotic susceptibility between Staphylococcus epidermidis and Staphylococcus saprophyticus.
    Richardson JF; Marples RR
    J Antimicrob Chemother; 1980 Jul; 6(4):499-510. PubMed ID: 6968747
    [No Abstract]   [Full Text] [Related]  

  • 10. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
    Castanheira M; Watters AA; Mendes RE; Farrell DJ; Jones RN
    J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel fusidic acid resistance determinant, fusF, in Staphylococcus cohnii.
    Chen HJ; Hung WC; Lin YT; Tsai JC; Chiu HC; Hsueh PR; Teng LJ
    J Antimicrob Chemother; 2015 Feb; 70(2):416-9. PubMed ID: 25313205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of the change in catalase activity of fucidin-resistant Staphyloccus aureus cultures].
    Kovács E; Kókai K; Mazarean HH
    Acta Microbiol Acad Sci Hung; 1965; 12(3):223-7. PubMed ID: 4285523
    [No Abstract]   [Full Text] [Related]  

  • 13. Fusidic acid resistance, mediated by fusB, in bovine coagulase-negative staphylococci.
    Yazdankhah SP; Asli AW; Sørum H; Oppegaard H; Sunde M
    J Antimicrob Chemother; 2006 Dec; 58(6):1254-6. PubMed ID: 17060340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal carriage and antibiotic susceptibility of Staphylococcus aureus in general practice.
    Gillett AP; Johnson T; Orton C; Wills R; Menday AP; Talbot DJ
    J R Coll Gen Pract; 1984 May; 34(262):255-7. PubMed ID: 6737360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal carriage of sodium fusidate resistant Staphylococcus aureus.
    Dealler S
    J R Coll Gen Pract; 1988 Apr; 38(309):171. PubMed ID: 3216357
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
    Memikoğlu KO; Bayar B; Kurt O; Cokça F
    Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
    Rennie RP
    J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
    Woodford N; Afzal-Shah M; Warner M; Livermore DM
    J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries.
    den Heijer CD; van Bijnen EM; Paget WJ; Stobberingh EE
    Future Microbiol; 2014; 9(6):737-45. PubMed ID: 25046521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.
    Pfaller MA; Castanheira M; Sader HS; Jones RN
    Int J Antimicrob Agents; 2010 Mar; 35(3):282-7. PubMed ID: 20036520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.